Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
AbCellera Biologics Inc (ABCL) Insider Trading Activity
Healthcare • Biotechnology • 586 employees
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Total Value
$1,058,718.55
Total Shares
479,100
Average Trade Value
$264,679.64
Most Active Insider
Thermopylae Holdings Ltd.
Total Activity: $739,977
Largest Single Transaction
$739,977
by Thermopylae Holdings Ltd. on Aug 29, 2024
30-Day Activity
1 Transaction
Volume: 56,125 shares
Value: $151,538
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Chief Executive Officer
Director, Officer, 10% Owner
|
Nov 25, 2024 | 56,125 | $151,538 | 898,000 (+6.3%) | Exercise/Conversion | |
|
Chief Executive Officer
Director, Officer, 10% Owner
|
Sep 20, 2024 | 56,125 | $151,538 | 841,875 (+6.7%) | Exercise/Conversion | |
|
10% Owner
|
Aug 29, 2024 | 283,516 | $739,977 | 56,086,009 (+0.5%) | Purchase | |
|
Chief Operating Officer
Director, Officer
|
Jun 21, 2024 | 83,334 | $15,667 | 2,123,456 (+3.9%) | Exercise/Conversion |